Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis
Abstract Background Novel abortive treatments for migraine, ditans and gepants, have promising implications in triptan-insufficient responders with minimal existing comparative data. Our study aims to synthesize evidence through a systematic review and network meta-analysis to assess the comparative...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-11-01
|
| Серія: | The Journal of Headache and Pain |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s10194-024-01904-1 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|